{"id":"NCT05850494","sponsor":"AstraZeneca","briefTitle":"Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma","officialTitle":"Randomized, DB, Crossover Study to Assess Bronchospasm Potentially Induced by HFO MDI vs. HFA MDI Propellant in Participants With Asthma Well/Partially Controlled on SABA With or Without Low-Dose ICS","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2023-05-02","primaryCompletion":"2023-08-21","completion":"2023-08-21","firstPosted":"2023-05-09","resultsPosted":"2025-07-30","lastUpdate":"2025-08-15"},"enrollment":52,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"HFA MDI","otherNames":["Propellant in MDI"]},{"type":"DRUG","name":"HFO MDI","otherNames":["Propellant in MDI"]}],"arms":[{"label":"Treatment A: HFO propellant only MDI","type":"EXPERIMENTAL"},{"label":"Treatment B: HFA propellant only MDI","type":"ACTIVE_COMPARATOR"}],"summary":"A study to assess bronchospasm potentially induced by HFO MDI as compared with HFA MDI in participants with well controlled or partially controlled asthma","primaryOutcome":{"measure":"Change From Baseline in Normalized Forced Expiratory Volume in 1 Second (FEV1) Area Under the Curve From 0 to 15 Minutes (AUC0-15 Min) Post-dose","timeFrame":"30 minutes prior to dosing and at 5, 15, and 30 minutes post-dose","effectByArm":[{"arm":"Treatment HFO","deltaMin":2.969,"sd":0.666},{"arm":"Treatment HFA","deltaMin":2.97,"sd":0.6463}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":1},"locations":{"siteCount":4,"countries":["United States"]},"refs":{"pmids":["32387408","31613151","16226443","10573240","16055882","22743675","8499054","40551410"],"seeAlso":["https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5985C00007&amp;attachmentIdentifier=ee73a15b-ba47-453b-b020-74fcd162e7a8&amp;fileName=d5985c00007-synopsis-redacted.pdf&amp;versionIdentifier="]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":52},"commonTop":["Fatigue","Pyrexia","Urinary tract infection","Dysgeusia","Nephrolithiasis"]}}